• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Oliver Kirschner
Dr. Oliver Kirschner
Dr. Oliver Kirschner

Dr. Oliver Kirschner

Partner

  • Hamburg Germany
Contact Me Today
+49 40 36803 0
vCard
Email me Call me
Featured award

JUVE 2025/2026

Frequently recommended lawyer for M&A

Scroll to featured award

Oliver clients include private equity investors, family offices and strategic investors from Germany and abroad, whom he advises on national and cross-border transactions. He is described by his clients as being “very active and strong” in negotiations showing profound knowledge of the market, in which his clients are active, and their priorities and expectations. Other clients emphasize his high level of expertise in healthcare transactions. His core expertise includes the structuring, negotiation and implementation of complex transactions in particular in the highly regulated healthcare sector on both the buy- and sell side including leveraged buyouts and related transactions for private equity sponsors and their portfolio companies.

Oliver has regularly lectured on legal topics in the area of healthcare transactions and is co-author of the handbook on medical and healthcare law (Beck'sches Formularbuch Medizin- und Gesundheitsrecht).

Oliver is Co-Head of the German and the International Life Sciences & Healthcare industry group and a member of the M&A and Private Equity practice groups at Taylor Wessing.

Expertise

Services and Groups

Corporate/M&A & capital markets
General corporate
Joint ventures

Sectors

Life sciences & healthcare
Health & social care and investors

CV

Since 2007 Partner, Taylor Wessing
2002 – 2007 Associate, international law firm, Düsseldorf
2005 – 2006 Secondee, Slaughter and May, Hong Kong
2002 Admitted as a lawyer, Düsseldorf
2001 Second state examination, Hamburg
2001 – 2003 Doctoral degree, Universität in Mainz
1998 – 1999 Studies, Hochschule für Sprache und Kultur, Peking
1998 First state examination, Regensburg
1993 – 1998 Degree in law, Universität Regensburg

Career

Since 2007 Partner, Taylor Wessing
2002 – 2007 Associate, international law firm, Düsseldorf
2005 – 2006 Secondee, Slaughter and May, Hong Kong

Education

2002 Admitted as a lawyer, Düsseldorf
2001 Second state examination, Hamburg
2001 – 2003 Doctoral degree, Universität in Mainz
1998 – 1999 Studies, Hochschule für Sprache und Kultur, Peking
1998 First state examination, Regensburg
1993 – 1998 Degree in law, Universität Regensburg

Publications

Post-Merger Integration und Corporate Governance bei chinesischen Outbound-Investitionen in Deutschland, in: Chinesische Outbound-Investitionen in Deutschland, Hrsg. Von Prof. Yuanshi Bu, 2014“

Kulturelle Besonderheiten bei Verhandlungen und Vertragsmanagement, Unternehmeredition M & A China / Deutschland 2013

Memberships & Associations

Gesellschaftsrechtliche Vereinigung (VGR)

Additional languages

English

Awards

JUVE 2025/2026

Featured

Frequently recommended lawyer for M&A

JUVE 2025/2026

highly competent in healthcare deals at the interface with medical law, client

Legal 500 2025

Recommended Lawyer for Mergers and Acquisitions Law

Legal 500 2025

Oliver Kirschner and Amir Ghassabeh have a particular talent for combining client needs, state-of-the-art M&A advice and deal strategy. Our go-to team for all mid-cap M&A deals.

Best lawyers: Mergers and acquisitions law

Recommended lawyer for Healthcare and life sciences

Frequently recommended lawyer for M&A

Leading individual: Mergers and Acquisitions Law

Ranked lawyer for Healthcare

Frequently recommended lawyer for M&A

Leading individual: Mergers and Acquisitions Law

Ranked with Chambers and Partners for Healthcare (Germany)

Key lawyer for Healthcare

Frequently recommended: M&A

Leading individual: Mergers and acquisitions

Frequently recommended lawyer for M&A

Frequently recommended: M&A healthcare

Experience

Successful financing and add on acquisitions for Oberberg Group

Oberberg Group on the successful refinancing of its existing credit lines. The new financing also served several add-on acquisitions. This included the internationally renowned private clinic Jägerwinkel am Tegernsee, which is expanding the treatment spectrum of the Group with its range of integrative holistic psychosomatics with a focus on interdisciplinary pain therapy. In addition, Panorama Fachklinik, an acute hospital for psychosomatics, and Privatklinik Hubertus im Allgäu, a specialist hospital for psychosomatics, psychotherapy and naturopathy, were acquired.

Press release
Ulf Gosejacob
Sabine Schomaker
Dr. Michael Beyer, Dipl.-Volkswirt
Dr. Oliver Kirschner
Christopher Peine

NORD Holding on the acquisition of Zentrum Gesundheit Group

NORD Holding, a leading private equity house, on the acquisition of the majority interest in Zentrum Gesundheit Group, a leading German group of ophthalmic surgery and diagnostic centres, from Waterland Private Equity. NORD Holding, together with the management and medical team, acquired a stake as a new partner and majority shareholder. In this deal the Taylor Wessing team again demonstrated its interdisciplinary expertise in the areas of healthcare M&A, regulatory and acquisition financing.

Press release
Dr. Oliver Kirschner
Dr. Oliver Klöck
Ulf Gosejacob
Maria Weiers
Dr. Anne Steinhardt
Christopher Peine
Dr. Michael Beyer, Dipl.-Volkswirt
Dr. Vanessa Christin Vollmar
Dr. Lars Hagen
Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt
Dr. Michael Brüggemann
Thanos Rammos, LL.M.
Dr. Daniel Tietjen

Oliver's news & insights

View Oliver's insights
White microscope on yellow background
Click here to find out more
Corporate/M&A & capital markets

Taylor Wessing advises Mercurius Health on the acquisition of MEDICLIN Robert Janker Klinik

6 November 2023

by multiple authors

Glass.Mapper.Sc.Fields.Image?.Alt
Germany

Chambers Europe 2022 recommends 28 Taylor Wessing lawyers from 21 Practice Areas whilst Data Protection is listed for the first time

21 March 2022

by multiple authors

Click here to find out more

Top Level Change at Taylor Wessing Germany: Olaf Kranz elected as new Managing Partner

30 April 2018

by multiple authors

Click here to find out more
View Oliver's insights

Related news & insights

Close-Up Of Modern Office Facade
Corporate/M&A & capital markets

Taylor Wessing advises Multiverse Group Limited and Multiverse GmbH on the acquisition of StackFuel GmbH

29 January 2026

by multiple authors

Click here to find out more
Hand Holding Blue Paper Airplane on green background
Careers

Oli Denne recognised in The Lawyer's Hot 100 2026

28 January 2026

by Oli Denne and Shane Gleghorn

Click here to find out more
Up Arrow
Corporate/M&A & capital markets

Advising Toho Global on its acquisition of Anime Limited

27 January 2026

by multiple authors

Click here to find out more
Overhead view of scientist using centrifuge machine
Life sciences & healthcare

Research and innovation as a competitive advantage – Legal framework for Life Sciences made in Europe

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Patterned pills
Life sciences & healthcare

Life Sciences Made in Europe – The European Commission’s Life Sciences Strategy 2030

27 January 2026
In-depth analysis

by Irina Rebin

Click here to find out more
Blood samples
Life sciences & healthcare

Adoption of Commission Implementing Regulation (EU) 2025/2086: New Rules on the Joint Clinical Assessment of Medical Devices and In Vitro Diagnostic Medical Devices

23 January 2026
Briefing

by Irina Rebin and Daniel Dietrich

Click here to find out more
Low Angle View Of Flags Waving
Logistics & transport

EU Inc.: Founders and companies with expansion plans must now think strategically

23 January 2026
Quick read

by Dr. Benedikt Groh and Fritz Krings

Click here to find out more
Office facade reflection
Life sciences & healthcare

Advising Nuclera on its extended Series C funding to US$87 million

22 January 2026

by Ross McNaughton and Oli Denne

Click here to find out more
Windows of modern futuristic glass
Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part one

21 January 2026
In-depth analysis

by multiple authors

Click here to find out more
Low angle view of futuristic skyscrapers
Life sciences & healthcare

Word on the street at the J.P. Morgan Healthcare Conference 2026: Part two

21 January 2026
In-depth analysis

by multiple authors

Click here to find out more
View all insights

Related people

Germany
Global

Dr. Amir-Said Ghassabeh

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Dr. Philip Cavaillès, Rechtsanwalt, Solicitor (England & Wales)

Dr. Philip Cavaillès

Partner

Munich
+49 172 64 28 499
Email me
View profile
Jan Riebeling

Dr. Jan Riebeling

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Sebastian Beyer

Dr. Sebastian Beyer, LL.M. (Auckland)

Salary Partner

Frankfurt
Duesseldorf
+49 69 97130 135
Email me
View profile
Michael Stein

Michael Stein

Partner

Frankfurt
+49 69 97130 0
Email me
View profile
Peter Hellich

Dr. Peter Hellich

Partner

Munich
+49 89 21038 0
Email me
View profile
Stephan Doom

Stephan Doom, Solicitor (England & Wales)|LL.M. (Nottingham)

Salary Partner

Frankfurt
+49 69 97130 0
Email me
View profile
Rembert T. Graf Kerssenbrock

Dr. Rembert T. Graf Kerssenbrock, LL.M. (Beijing)

Senior Associate

Hamburg
+49 40 36803 0
Email me
View profile
Anne Kathrin Hoppe

Anne-Kathrin Hoppe

Salary Partner

Hamburg
+49 40 36803 0
Email me
View profile
Hassan Sohbi

Hassan Sohbi

Associated Partner

Frankfurt
+49 69 97130 0
Email me
View profile
Full team
Rachael Potts

Rachael Roberts

Associate

London
+44 20 7300 7000
Email me
View profile
Geraerts-Marnix

Marnix Geraerts

Partner

Amsterdam
+31 88 02 43 219
Email me
View profile

Jack Coventry

Senior Associate

London
+44 20 7300 7000
Email me
View profile
Alexander R. Roth

Alexander R. Roth, M.Jur. (Oxford)

Partner

San Francisco
New York
+1 650 6668403
Email me
View profile
josef fuss

Josef Fuss

Partner

London
+44 20 7300 4110
Email me
View profile
Stephan Doom

Stephan Doom, Solicitor (England & Wales)|LL.M. (Nottingham)

Salary Partner

Frankfurt
+49 69 97130 0
Email me
View profile
Michiel Boer

Michiel Boer

Partner

Amsterdam
+31 88 02 43 264
Email me
View profile

Dr. Amir-Said Ghassabeh

Partner

Hamburg
+49 40 36803 0
Email me
View profile
Jeroen Vollebergh

Jeroen Vollebergh

Counsel

Amsterdam
+31 88 024 3228
Email me
View profile
Dr. Philip Cavaillès, Rechtsanwalt, Solicitor (England & Wales)

Dr. Philip Cavaillès

Partner

Munich
+49 172 64 28 499
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing